Aclaris Therapeutics, Inc.ACRS
What Aclaris Therapeutics, Inc. does.
We are a clinical-stage biopharmaceutical company focused on discovering and developing novel small and large molecule product candidates for immuno-inflammatory diseases. Our proprietary KINect drug discovery platform coupled with our integrated discovery approach to small and large molecules enables us to identify and advance product candidates designed to have superior target affinity, specificity and potency. We are seeking to identify and consummate transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our novel product candidates.
We are dedicated to developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options . Our approach to achieving this goal includes the following key elements:
● Leverage discovery, research and development expertise. We have state-of-the-art capabilities and expertise in small molecule and antibody development, including cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, translational research, in vivo efficacy models, structure-based drug design (“SBDD”), and bioanalytical, computational, and medicinal chemistry. In addition, our team of scientists and professionals has broad experience in clinical development and strategy across atopic, respiratory, inflammatory and immunologic diseases.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $6.5M | $6.8M | $29.8M | $31.2M | $18.7M | $7.8M |
| Net income | -$51.0M | -$90.9M | -$86.9M | -$88.5M | -$132.1M | -$64.9M |
| Free cash flow | -$39.1M | -$52.4M | -$68.2M | -$79.6M | -$20.2M | -$47.2M |
More on ACRS.
- Aclaris Therapeutics, Inc. summary
- Aclaris Therapeutics, Inc. financial statements
- Aclaris Therapeutics, Inc. key metrics
- Aclaris Therapeutics, Inc. health scores and style box
- Aclaris Therapeutics, Inc. earnings
- Aclaris Therapeutics, Inc. dividends
- Aclaris Therapeutics, Inc. valuation
- Aclaris Therapeutics, Inc. ownership and insiders
- Aclaris Therapeutics, Inc. peers
Figures from Aclaris Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.